TScan Therapeutics
TCRX
TCRX
28 hedge funds and large institutions have $14.8M invested in TScan Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
49% less capital invested
Capital invested by funds: $29M → $14.8M (-$14.2M)
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$142K | |
| 2 | +$48.9K | |
| 3 | +$31K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$17.4K |
| 5 |
Renaissance Technologies
New York
|
+$16K |
Top Sellers
| 1 | -$203K | |
| 2 | -$88K | |
| 3 | -$67.1K | |
| 4 |
Morgan Stanley
New York
|
-$34.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.78K |